• Viking Therapeutics will release third-quarter 2026 financial results following the market close on Oct. 28, 2026.
• A conference call covering results and corporate updates is scheduled for Oct. 28 at 4:30 p.m. Eastern Time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viking Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610211605PR_NEWS_USPR_____LA77329) on October 21, 2026, and is solely responsible for the information contained therein.